Current management of diabetic tractional retinal detachments

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
Bevacizumab 4 endocrinologydiseasesdrugs
diabetes mellitus 1 endocrinologydiseases
diabetic retinopathy 2 endocrinologydiseases
type 1 diabetes mellitus 1 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Bevacizumab 35767 TRD/RRDs (47.0 vs. 21.3%; P < 0.0001) and macula-involving detachments (74.5 vs. 60.0%; P < 0.0001).[[136]] Bevacizumab Pre-operative intravitreal injections of bevacizumab to cause involution of neovascularization was first
Bevacizumab 36198 bevacizumab improves surgical outcomes[[143]] but others state that final VAs are not affected.[[144]] Bevacizumab administered 1–14 days before surgery improved the ease of surgery in complex cases of TRD or vitreous
Bevacizumab 36860 fibrovascular complexes without progression and thickening of the fibrous component or worsening of the TRD. Bevacizumab appeared to simplify surgery because the fibrovascular complex could be separated from the retina without
Bevacizumab 37303 PDR.Figure 8This fovea-involving traction retinal detachment is accompanied by active neovascularization. Bevacizumab was injected intravitreally 3 days prior to surgery to decrease the risk of intraoperative bleedingOther
Select Disease Character Offset Disease Term Instance
diabetes mellitus 21655 Figs. 3-5.Figure 3Traction retinal detachment of the left eye of a 32-year-old patient with type 1 diabetes mellitus . The visual acuity was 20/160. The right eye was blind for the past 5 years following failed surgery
diabetic retinopathy 514 12/2018AbstractTwenty-five percent of diabetes-related vision loss stems from complications of proliferative diabetic retinopathy (PDR). Panretinal photocoagulation has been the preferred treatment of high-risk PDR for decades and
diabetic retinopathy 2942 patients.Vision loss in the other 25% of patients with DR stems from complications of proliferative diabetic retinopathy (PDR). Approximately 17 million patients throughout the world have PDR[[8]] and without treatment more
type 1 diabetes mellitus 21648 shown in Figs. 3-5.Figure 3Traction retinal detachment of the left eye of a 32-year-old patient with type 1 diabetes mellitus . The visual acuity was 20/160. The right eye was blind for the past 5 years following failed surgery

You must be authorized to submit a review.